Atlantia Clinical Trials Posted January 31, 2022 Report Share Posted January 31, 2022 The investigational product that will be tested in this study is being developed as a dietary supplement that is intended to improve Irritable Bowel Syndrome (IBS) symptoms in individuals IBS. There are a small number of potential side effects that may happen as result of introducing the investigational product to the normal diet (e.g. indigestion. Bloating, changes in bowel habit, changes in hunger levels and appetite etc. or allergic reaction). Since the product is investigational, there may be other risks that are unknown. Due to the sensitive nature of the questionnaires some of the questions may seem invasive due to their personal nature. You may or may not benefit from taking part in this study. However, in the future other people may benefit from this research. You will receive a health check (i.e., monitoring of blood pressure, heart rate, temperature, blood safety profile results) if you participate in this study. If you agree to take part in this study and after you sign the consent form, over a 15-week period you will attend 3 visits at the study site and two phone-call check-ins during which you will undergo a health check, be asked to provide blood and stool samples and complete a number of questionnaires relating to your IBS symptoms. You will be asked to consume a study product or a visually identical placebo once a day for 84 days (12 weeks). To apply click the link below. https://atlantiaclinicaltrials.com/chicago/study/ibs-study Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.